Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)

Status Completed

Clinical Trial Summary

To evaluate the immune response and the safety of a primary series schedule that includes V419 (PR5I) at 2 and 6 months of age and Pediacel at 4 months of age

Primary objectives

- To demonstrate that the mixed schedule induces acceptable responses for Hepatitis B (HB) one month after completion of the mixed schedule

- To demonstrate that the mixed schedule induces acceptable responses for Haemophilus influenzae type b (Hib) one month after completion of the mixed schedule

Secondary objectives

- To describe the antibody response to all PR5I antigens one month after completion of the mixed schedule

- To describe the antibody response to meningococcal serogroup C (MCC) conjugate vaccine one month after the second dose of MenC vaccine

- To describe the safety profile after each dose of study vaccines administered

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01839188
Study type	Interventional
Source	MCM Vaccines B.V.
Contact
Status	Completed
Phase	Phase 3
Start date	May 1, 2013
Completion date	March 19, 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03726216` - Xydalba Utilization Registry in France
Completed	`NCT03605498` - OR PathTrac (Tracking Intra-operative Bacterial Transmission)
Withdrawn	`NCT05269121` - Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections	Phase 1/Phase 2
Completed	`NCT02541695` - Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli	N/A
Recruiting	`NCT02074865` - Children's Antibiotic Resistant Infections in Low Income Countries	N/A
Completed	`NCT01932034` - Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software	N/A
Completed	`NCT01689207` - To Investigate the Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI)	Phase 1
Completed	`NCT01412801` - Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings	Phase 2
Not yet recruiting	`NCT01159470` - The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children	N/A
Completed	`NCT00983255` - Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)	Phase 1
Completed	`NCT00799591` - French Study In ICU Patients Treated With Tigecycline	N/A
Completed	`NCT00678106` - Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections	Phase 1
Completed	`NCT00478855` - Tazocin Intervention Study	Phase 4
Completed	`NCT01074775` - Human Innate Immune Responses To Mycobacterial Aerodigestive Tract Infection	N/A
Terminated	`NCT00431028` - Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery	Phase 1/Phase 2
Not yet recruiting	`NCT03634904` - Serum Ceftazidime Concentrations in Hemodialysis Patients	N/A
Recruiting	`NCT05684705` - Study to Investigate the Penetration of Rifabutin Into the Lung After Multiple Intravenous Administrations of BV100	Phase 1
Recruiting	`NCT03858387` - PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients
Enrolling by invitation	`NCT04764058` - Efficacy and Safety of Colistin Based Antibiotic Therapy	Phase 1/Phase 2
Recruiting	`NCT06319235` - Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®	Phase 1/Phase 2